B. Woggon

1.2k total citations
62 papers, 599 citations indexed

About

B. Woggon is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, B. Woggon has authored 62 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 17 papers in Pharmacology and 11 papers in Clinical Psychology. Recurrent topics in B. Woggon's work include Schizophrenia research and treatment (18 papers), Treatment of Major Depression (14 papers) and Psychiatric care and mental health services (8 papers). B. Woggon is often cited by papers focused on Schizophrenia research and treatment (18 papers), Treatment of Major Depression (14 papers) and Psychiatric care and mental health services (8 papers). B. Woggon collaborates with scholars based in Switzerland, Germany and Slovenia. B. Woggon's co-authors include Jules Angst, Peter Graw, Hans U. Fisch, Anna Wirz‐Justice, P Kielholz, Hans H. Stassen, Joseph Schoepf, D Bobon, A. Dittrich and C Scharfetter and has published in prestigious journals such as The Lancet, The British Journal of Psychiatry and Psychopharmacology.

In The Last Decade

B. Woggon

58 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. Woggon Switzerland	11	274	172	131	123	105	62	599
W Pöldinger Switzerland	14	248 0.9×	134 0.8×	116 0.9×	117 1.0×	117 1.1×	76	753
P Kielholz Switzerland	15	174 0.6×	199 1.2×	177 1.4×	148 1.2×	88 0.8×	92	803
Goodwin Fk United States	18	413 1.5×	244 1.4×	105 0.8×	134 1.1×	123 1.2×	44	1.1k
Marie‐Josée Filteau Canada	6	190 0.7×	228 1.3×	45 0.3×	111 0.9×	68 0.6×	7	539
Otto‐Michael Lesch Austria	13	165 0.6×	140 0.8×	59 0.5×	71 0.6×	77 0.7×	30	710
C R Lake United States	14	189 0.7×	99 0.6×	35 0.3×	68 0.6×	101 1.0×	30	905
Javaid I. Javaid United States	17	256 0.9×	100 0.6×	47 0.4×	37 0.3×	85 0.8×	34	727
Stephen Kaplita United States	9	609 2.2×	268 1.6×	62 0.5×	198 1.6×	94 0.9×	18	961
Gillin Jc United States	15	184 0.7×	103 0.6×	118 0.9×	167 1.4×	65 0.6×	35	652
Marie‐France Poirier France	17	412 1.5×	168 1.0×	36 0.3×	112 0.9×	221 2.1×	34	964

Countries citing papers authored by B. Woggon

Since Specialization

Citations

This map shows the geographic impact of B. Woggon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Woggon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Woggon more than expected).

Fields of papers citing papers by B. Woggon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Woggon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Woggon. The network helps show where B. Woggon may publish in the future.

Co-authorship network of co-authors of B. Woggon

This figure shows the co-authorship network connecting the top 25 collaborators of B. Woggon. A scholar is included among the top collaborators of B. Woggon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Woggon. B. Woggon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baumann, Uwe, et al.. (2015). Syndromes and Scales in the AMP-System1. PubMed. 20. 74–87. 1 indexed citations

Woggon, B.. (1997). Treatment of Bipolar Disorder, Depressed Phase Augmentation/Switching Strategies. PubMed. 25. 78–87. 1 indexed citations

Woggon, B., et al.. (1997). A Case of Serotonin Syndrome Caused by Venlafaxine and Lithium. Pharmacopsychiatry. 30(6). 272–273. 34 indexed citations

Stassen, Hans H., et al.. (1995). Speaking behavior and voice sound characteristics associated with negative schizophrenia. Journal of Psychiatric Research. 29(4). 277–296. 31 indexed citations

Angst, Jules, Per Bech, J. Bruinvels, et al.. (1994). Report on the Fifth Consensus Conference: Methodology of Long-Term Clinical Trials in Psychiatry. Pharmacopsychiatry. 27(3). 101–107. 7 indexed citations

Woggon, B.. (1992). Methodology of measuring the efficacy of antidepressants — European viewpoint. Psychopharmacology. 106(S1). S90–S92. 5 indexed citations

Angst, Jules, Per Bech, D Bobon, et al.. (1991). Report on the Third Consensus Conference on the Methodology of Clinical Trials with Antipsychotic Drugs. Pharmacopsychiatry. 24(5). 149–152. 7 indexed citations

Woggon, B.. (1991). [Pharmacotherapy of depression].. PubMed. 80(38). 976–9. 6 indexed citations

Woggon, B.. (1988). Unsolved Problems in the Pharmacotherapy of Depression. PubMed. 5. 159–165. 2 indexed citations

10.

Møller, Henrik, Werner Kissling, Pierre Baumann, et al.. (1988). Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities. Pharmacopsychiatry. 21(6). 285–287. 6 indexed citations

11.

Meyer, Jörg, B. Woggon, & A Küpfer. (1988). Importance of Oxidative Polymorphism on Clinical Efficacy and Side-Effects of Imipramine - A Retrospective Study. Pharmacopsychiatry. 21(6). 365–366. 15 indexed citations

12.

Baumann, Pierre, et al.. (1988). Acetylation of maprotiline and desmethylmaprotiline in depressive patients phenotyped with sulfamidine, debrisoquine, and mephenytoin.. PubMed. 38(2). 292–6. 2 indexed citations

13.

Woggon, B., et al.. (1985). Comparison of AMP System and Comprehensive Psychopathological Rating Scale with Regard to Contents. Neuropsychobiology. 13(3). 117–120. 4 indexed citations

14.

Woggon, B., et al.. (1982). Deutschsprachige Version derComprehensive Psychopathological Rating Scale (CPRS). International Pharmacopsychiatry. 17(4). 314–337. 2 indexed citations

15.

Woggon, B.. (1979). [Discontinuation of neuroleptics in chronic schizophrenics. I. Summary of the literature].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(1). 34–56. 3 indexed citations

16.

Woggon, B., Jörg Fleischhauer, & A. Widmer. (1979). [Influence of diagnosis, hospital and sex on the effects of bromperidol].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(4). 213–27. 1 indexed citations

17.

Woggon, B.. (1978). Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 78(1). 155–72. 12 indexed citations

18.

Woggon, B. & Jules Angst. (1978). [Principles and regulations for clinical pilot studies on psycholeptic drugs (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28(8). 1257–9. 1 indexed citations

19.

Woggon, B.. (1978). [Penfluridol. Results of a year-long clinical trial].. PubMed. 13(1). 1–15. 1 indexed citations

20.

Woggon, B., et al.. (1977). [Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 12(4). 193–209. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact